EVALUATION OF MENTAL STATUS AND ITS CORRECTION AGOMELATINE IN PATIENTS WITH ACUTE CORONARY SYNDROME

EVALUATION OF MENTAL STATUS AND ITS CORRECTION AGOMELATINE IN PATIENTS WITH ACUTE CORONARY SYNDROME

Continuous sampling method using aquestionnaireHospitalAnxiety and Depression Scale (GSHTD) held survey 250 patients with acute coronary syndrome (ACS) admitted to the emergency Department of cardiologyInstituteofCardiology, SB of RAMS. Of these, 85 people (34%) were detected symptoms of anxiety and...

Full description

Bibliographic Details
Main Authors:	T. M. Poponina, K. I. Gunderina, Yu. S. Poponina, V. A. Markov
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2013-12-01
Series:	Bûlleten' Sibirskoj Mediciny
Subjects:	acute coronary syndrome, anxiety-depressive syndrome, agomelatine
Online Access:	https://bulletin.tomsk.ru/jour/article/view/304

Similar Items

Suspected Agomelatine-induced restless legs syndrome: a case report
by: Mustafa Abdul Karim, et al.
Published: (2021-04-01)

Modern potential of thrombotic complication prevention among patients with acute coronary syndrome without ST segment elevation in real clinical practice (Part I)
by: T. M. Poponina, et al.
Published: (1970-01-01)

DEPRESSION AND ANXIETY IN PATIENT WITH ACUTE CORONARY SYNDROME
by: Kadek Dwi Krisnayanti
Published: (2013-07-01)

AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: N. Yu. Shimohina, et al.
Published: (2017-03-01)

THE RELATIONSHIP BETWEEN DEPRESSION, ANXIETY AND ACUTE CORONARY SYNDROME
by: Made Widiyanti
Published: (2013-03-01)

Impact of Experiencing Acute Coronary Syndrome Prior to Open Heart Surgery on Psychiatric Status
by: Volkan Yüksel, et al.

Optimising the treatment of patients with acute coronary syndrome without ST segment elevation
by: T. M. Poponina, et al.
Published: (1970-01-01)

PECULIARITIES OF PARAMETERS OF ECHOCARDIOGRAPHY IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITH COMORBID ANXIETY AND DEPRESSIVE DISORDERS
by: N. Yu. Shimohina, et al.
Published: (2014-12-01)

Approaches to therapy for depressions in neurology: prospects for the use of agomelatine
by: D. V. Romanov, et al.
Published: (2018-12-01)

Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE
by: Medvedev VE
Published: (2017-04-01)

The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice
by: Domenico De Berardis, et al.
Published: (2013-06-01)

Screening for symptoms of anxiety and depression in patients admitted to a university hospital with acute coronary syndrome
by: Carolina Casanova Meneghetti, et al.

Evaluation of Multidisciplinary Collaborative Care in Patients with Acute Coronary Syndrome and Depression and/or Anxiety Disorders
by: Feng Liang, et al.
Published: (2017-05-01)

Work-related outcome after acute coronary syndrome: Implications of complex cardiac rehabilitation in occupational medicine
by: Monica Lamberti, et al.
Published: (2016-08-01)

Differentiated approach and indications for optimization of agomelatine therapy for endogenous depression
by: L. I. Abramova, et al.
Published: (2019-06-01)

Agomelatine – pharmacological properties and use in psychiatric practice
by: Marcin Siwek, et al.
Published: (2019-06-01)

Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial
by: Che T, et al.
Published: (2018-06-01)

Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model
by: Ahmet Yardimci, et al.
Published: (2021-06-01)

Drug use evaluation: A two‐year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder
by: Shek Ming Leung
Published: (2021-08-01)

Effect of aromatherapy on anxiety in patients with acute coronary syndrome hospitalized in cardiac care unit
by: Mahmood Reza Nematollahi, et al.
Published: (2017-05-01)

Impact of anxiety and depression on morbidity and mortality of patients with coronary syndrome
by: Denise Meira Altino, et al.

Dysaggregants effect of platelet aggregation in patients with non-5T segment elevation acute coronary syndrome
by: T M Poponina, et al.
Published: (2004-08-01)

4T Zikr in Anxiety Reduction in Acute Coronary Syndrome Patients
by: Sukarni Sukarni, et al.
Published: (2015-08-01)

Female Psychological Adjustment Following an Acute Coronary Syndrome
by: Joana Prata, et al.
Published: (2017-05-01)

ACUTE CORONARY SYNDROME IN ELDERLY: CURRENT STATUS AND UNRESOLVED ISSUES
by: О. N. Tkacheva, et al.
Published: (2017-06-01)

Relationship of Anxiety, Stress, and Depression with Spiritual Health in Patients with Acute Coronary Artery Disease
by: Leila Ghanbari Afra, et al.
Published: (2017-09-01)

Antiaggregant influence on platelet aggregation in patients with acute coronary syndrome without ST segment elevation
by: T. M. Poponina, et al.
Published: (2006-10-01)

Associated Factors of Anxiety among Acute Coronary Syndrome Patients in Kelantan and Terengganu
by: Wan Adnan Wan-Nor-Asyikeen, et al.
Published: (2017-10-01)

Chronic agomelatine treatment prevents comorbid depression in the post-status epilepticus model of acquired epilepsy through suppression of inflammatory signaling
by: Jana Tchekalarova, et al.
Published: (2018-07-01)

Relationship Between Survivors' Perceived Health Status Following Acute Coronary Syndrome and Depression Symptoms During Early Recovery Phase
by: Nah-Mee Shin, PhD, APRN, BC, et al.
Published: (2010-12-01)

Relationship between Symptoms of Depression and Anxiety with Major Adverse Cardiac Event in 7 days in Patients with Acute Coronary Syndrome in Cipto Mangunkusumo Hospital
by: Diah Pravita Sari, et al.
Published: (2018-12-01)

Assessment of the innovative quality of agomelatine through the Innovation Assessment Algorithm
by: Liliana Civalleri, et al.
Published: (2012-09-01)

Novel Conformationally Constrained Analogues of Agomelatine as New Melatoninergic Ligands
by: Marouan Rami, et al.
Published: (2012-12-01)

UV SPECTROPHOTOMETRIC METHOD FOR QUANTITATIVE DETERMINATION OF AGOMELATINE IN COATED TABLETS
by: Fábio de Souza Barbosa, et al.
Published: (2017-12-01)

Depression in Acute Coronary Syndrome Patients: A Cross-sectional Study in Malaysia
by: Wan Nor Asyikeen Wan Adnan, et al.
Published: (2020-08-01)

Management of acute coronary syndrome in older adults (data from russian federal acute coronary syndrome registry)
by: E V Ocshepkova, et al.
Published: (2018-03-01)

Peculiarities of Platelet Metabolism in Patients with Acute Coronary Syndrome with Anxiety–Depressive Disorders and Informativity of Enzymes in the Forecast of Development of Cardiovascular Complications
by: Natalya Yu. Shimokhina, et al.
Published: (2020-07-01)

Clinico-Pathogenetic Regularities of Evaluation of the Effectiveness of the Restorative Treatment in Patients After Acute Coronary Syndrome at the Stages of Rehabilitation
by: Roksolana Nesterak
Published: (2019-12-01)

Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects
by: Fang Tang, et al.
Published: (2016-01-01)

Chest Pain with Acute Coronary Syndrome
by: Alisa Wray, MD
Published: (2018-04-01)